chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 29.0
Sex: F
Vaccine: COVID19-2
Symptoms: Urticaria
Clinical narrative: At approximately 4am on Sunday 11/13 (~6 days post vaccination) I woke up with right knee pain and swelling. Later that same day, the pain and swelling spread to my bilateral shoulders, bilateral knees, bilateral ankles, bilateral wrists, and finger joints. I also developed welts on my skin when anything touched it, as well as a diffuse red macular rash on my chest on neck. I felt feverish but did not check my temperature. On Tuesday 11/15 I went to the ER and was diagnosed with a suspect delayed hypersensitivity reaction to the booster. I was given IV fluids, steroids, and antihistamines. I was started on a steroid and antihistamine course and symptoms are resolving at the time of writing this report, but are still moderately present. The ER I presented to was ER. The booster I received on 11/7 was my 4th vaccination overall -- my others were the Pfizer vaccines done on 12/20/2020, 1/6/2021, and 10/13/2021.
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest X-ray normal, Coagulation test abnormal, Computerised tomogram abnormal, Cough, Death
Clinical narrative: COVID+ 11/8/2022 - Vaccination status J&J x1 BRIEF OVERVIEW: Discharge Provider: DO Primary Care Physician at Discharge: DO   Admission Date: 11/8/2022   Active Hospital Problems   Diagnosis Date Noted POA ? COVID-19 11/09/2022 Unknown ? Acute hypoxic respriatory failure due to COVID-19   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: AKI (acute kidney injury)  [N17.9] Supratherapeutic INR [R79.1] Hematoma of rectus sheath, initial encounter [S30.1XXA] COVID [U07.1] COVID-19 [U07.1] Respiratory arrest [R09.2]   HOSPITAL COURSE: Patient is a 69 y.o. male with a past medical history of metastatic prostate cancer, hypertension, hyperlipidemia, GERD, rheumatoid arthritis who presents today with symptoms of severe abdominal pain, cough and shortness of breath.  Patient states that he has been congested for approximately the last month with his significant other testing positive for COVID-19 1 week ago. He has continued coughing with sudden development of abdominal pain from coughing so much.   Upon arrival to facilitY, imaging was performed showing large right rectus sheath hematoma without evidence of active bleeding.  Patient does take Coumadin at home and was noted to be supratherapeutic on coagulation studies.  Patient was also found to be COVID-19 positive with no evidence of pneumonia on chest x-ray.  Patient did receive 1 dose of vitamin K in the emergency department for supratherapeutic INR of 8. Patient was initially admitted today oncology service for further treatment. While on the floor he had significant desaturation and ultimately a code blue is called. He receives one round of compressions and epinephrine and ROSC is achieved. He is intubated and requires multiple pressors for circulatory support.    Upon admission to the ICU the patient has a central and arterial line placed. He is found to have a 3g Hbg drop and has increasing pressor requirements. During his stay in the ICU he eventually required CRRT for worsening kidney function. He required 4 pressors and stress dose steroids with poor prognosis.  On 11/11/2022, resident team called significant other and 1st degree sister to discuss ongoing need for dialysis and raising pressor requirements despite adequate volume resuscitation.  Both of them agreed in his current state he would not want repeat resuscitation with chest compressions and code status was changed to do not resuscitate.  Around 8:00 p.m. on the same day, patient's pressor requirements increasing and lactate continues to up trend. Patient's significant other as well as only first degree sister were contacted regarding worsening clinical status. Both expressed that patient would have not wanted to pursue aggressive medical care in this clinical sitting as things don't seem to be improving. Goals of cares were discussed and both parties expressed their wishes totransition to comfort care.  At around 3:15 a.m., resident team called to bedside to pronounce patient death.  Patient was seen and examined, time of death was 3:25 a.m. on 11/12/2022.
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dialysis, Dyspnoea, Endotracheal intubation, General physical health deterioration, Haemofiltration
Clinical narrative: COVID+ 11/8/2022 - Vaccination status J&J x1 BRIEF OVERVIEW: Discharge Provider: DO Primary Care Physician at Discharge: DO   Admission Date: 11/8/2022   Active Hospital Problems   Diagnosis Date Noted POA ? COVID-19 11/09/2022 Unknown ? Acute hypoxic respriatory failure due to COVID-19   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: AKI (acute kidney injury)  [N17.9] Supratherapeutic INR [R79.1] Hematoma of rectus sheath, initial encounter [S30.1XXA] COVID [U07.1] COVID-19 [U07.1] Respiratory arrest [R09.2]   HOSPITAL COURSE: Patient is a 69 y.o. male with a past medical history of metastatic prostate cancer, hypertension, hyperlipidemia, GERD, rheumatoid arthritis who presents today with symptoms of severe abdominal pain, cough and shortness of breath.  Patient states that he has been congested for approximately the last month with his significant other testing positive for COVID-19 1 week ago. He has continued coughing with sudden development of abdominal pain from coughing so much.   Upon arrival to facilitY, imaging was performed showing large right rectus sheath hematoma without evidence of active bleeding.  Patient does take Coumadin at home and was noted to be supratherapeutic on coagulation studies.  Patient was also found to be COVID-19 positive with no evidence of pneumonia on chest x-ray.  Patient did receive 1 dose of vitamin K in the emergency department for supratherapeutic INR of 8. Patient was initially admitted today oncology service for further treatment. While on the floor he had significant desaturation and ultimately a code blue is called. He receives one round of compressions and epinephrine and ROSC is achieved. He is intubated and requires multiple pressors for circulatory support.    Upon admission to the ICU the patient has a central and arterial line placed. He is found to have a 3g Hbg drop and has increasing pressor requirements. During his stay in the ICU he eventually required CRRT for worsening kidney function. He required 4 pressors and stress dose steroids with poor prognosis.  On 11/11/2022, resident team called significant other and 1st degree sister to discuss ongoing need for dialysis and raising pressor requirements despite adequate volume resuscitation.  Both of them agreed in his current state he would not want repeat resuscitation with chest compressions and code status was changed to do not resuscitate.  Around 8:00 p.m. on the same day, patient's pressor requirements increasing and lactate continues to up trend. Patient's significant other as well as only first degree sister were contacted regarding worsening clinical status. Both expressed that patient would have not wanted to pursue aggressive medical care in this clinical sitting as things don't seem to be improving. Goals of cares were discussed and both parties expressed their wishes totransition to comfort care.  At around 3:15 a.m., resident team called to bedside to pronounce patient death.  Patient was seen and examined, time of death was 3:25 a.m. on 11/12/2022.
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Haemoglobin decreased, Intensive care, Oxygen saturation decreased, Renal impairment, Respiratory arrest
Clinical narrative: COVID+ 11/8/2022 - Vaccination status J&J x1 BRIEF OVERVIEW: Discharge Provider: DO Primary Care Physician at Discharge: DO   Admission Date: 11/8/2022   Active Hospital Problems   Diagnosis Date Noted POA ? COVID-19 11/09/2022 Unknown ? Acute hypoxic respriatory failure due to COVID-19   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: AKI (acute kidney injury)  [N17.9] Supratherapeutic INR [R79.1] Hematoma of rectus sheath, initial encounter [S30.1XXA] COVID [U07.1] COVID-19 [U07.1] Respiratory arrest [R09.2]   HOSPITAL COURSE: Patient is a 69 y.o. male with a past medical history of metastatic prostate cancer, hypertension, hyperlipidemia, GERD, rheumatoid arthritis who presents today with symptoms of severe abdominal pain, cough and shortness of breath.  Patient states that he has been congested for approximately the last month with his significant other testing positive for COVID-19 1 week ago. He has continued coughing with sudden development of abdominal pain from coughing so much.   Upon arrival to facilitY, imaging was performed showing large right rectus sheath hematoma without evidence of active bleeding.  Patient does take Coumadin at home and was noted to be supratherapeutic on coagulation studies.  Patient was also found to be COVID-19 positive with no evidence of pneumonia on chest x-ray.  Patient did receive 1 dose of vitamin K in the emergency department for supratherapeutic INR of 8. Patient was initially admitted today oncology service for further treatment. While on the floor he had significant desaturation and ultimately a code blue is called. He receives one round of compressions and epinephrine and ROSC is achieved. He is intubated and requires multiple pressors for circulatory support.    Upon admission to the ICU the patient has a central and arterial line placed. He is found to have a 3g Hbg drop and has increasing pressor requirements. During his stay in the ICU he eventually required CRRT for worsening kidney function. He required 4 pressors and stress dose steroids with poor prognosis.  On 11/11/2022, resident team called significant other and 1st degree sister to discuss ongoing need for dialysis and raising pressor requirements despite adequate volume resuscitation.  Both of them agreed in his current state he would not want repeat resuscitation with chest compressions and code status was changed to do not resuscitate.  Around 8:00 p.m. on the same day, patient's pressor requirements increasing and lactate continues to up trend. Patient's significant other as well as only first degree sister were contacted regarding worsening clinical status. Both expressed that patient would have not wanted to pursue aggressive medical care in this clinical sitting as things don't seem to be improving. Goals of cares were discussed and both parties expressed their wishes totransition to comfort care.  At around 3:15 a.m., resident team called to bedside to pronounce patient death.  Patient was seen and examined, time of death was 3:25 a.m. on 11/12/2022.
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Respiratory tract congestion, Resuscitation, SARS-CoV-2 test positive
Clinical narrative: COVID+ 11/8/2022 - Vaccination status J&J x1 BRIEF OVERVIEW: Discharge Provider: DO Primary Care Physician at Discharge: DO   Admission Date: 11/8/2022   Active Hospital Problems   Diagnosis Date Noted POA ? COVID-19 11/09/2022 Unknown ? Acute hypoxic respriatory failure due to COVID-19   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: AKI (acute kidney injury)  [N17.9] Supratherapeutic INR [R79.1] Hematoma of rectus sheath, initial encounter [S30.1XXA] COVID [U07.1] COVID-19 [U07.1] Respiratory arrest [R09.2]   HOSPITAL COURSE: Patient is a 69 y.o. male with a past medical history of metastatic prostate cancer, hypertension, hyperlipidemia, GERD, rheumatoid arthritis who presents today with symptoms of severe abdominal pain, cough and shortness of breath.  Patient states that he has been congested for approximately the last month with his significant other testing positive for COVID-19 1 week ago. He has continued coughing with sudden development of abdominal pain from coughing so much.   Upon arrival to facilitY, imaging was performed showing large right rectus sheath hematoma without evidence of active bleeding.  Patient does take Coumadin at home and was noted to be supratherapeutic on coagulation studies.  Patient was also found to be COVID-19 positive with no evidence of pneumonia on chest x-ray.  Patient did receive 1 dose of vitamin K in the emergency department for supratherapeutic INR of 8. Patient was initially admitted today oncology service for further treatment. While on the floor he had significant desaturation and ultimately a code blue is called. He receives one round of compressions and epinephrine and ROSC is achieved. He is intubated and requires multiple pressors for circulatory support.    Upon admission to the ICU the patient has a central and arterial line placed. He is found to have a 3g Hbg drop and has increasing pressor requirements. During his stay in the ICU he eventually required CRRT for worsening kidney function. He required 4 pressors and stress dose steroids with poor prognosis.  On 11/11/2022, resident team called significant other and 1st degree sister to discuss ongoing need for dialysis and raising pressor requirements despite adequate volume resuscitation.  Both of them agreed in his current state he would not want repeat resuscitation with chest compressions and code status was changed to do not resuscitate.  Around 8:00 p.m. on the same day, patient's pressor requirements increasing and lactate continues to up trend. Patient's significant other as well as only first degree sister were contacted regarding worsening clinical status. Both expressed that patient would have not wanted to pursue aggressive medical care in this clinical sitting as things don't seem to be improving. Goals of cares were discussed and both parties expressed their wishes totransition to comfort care.  At around 3:15 a.m., resident team called to bedside to pronounce patient death.  Patient was seen and examined, time of death was 3:25 a.m. on 11/12/2022.
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Coagulation test abnormal, Computerised tomogram, Computerised tomogram abnormal, Cough, Death
Clinical narrative: COVID+ 11/8/2022 - Vaccination status J&J x1 BRIEF OVERVIEW: Discharge Provider: DO Primary Care Physician at Discharge: DO   Admission Date: 11/8/2022   Active Hospital Problems   Diagnosis Date Noted POA ? COVID-19 11/09/2022 Unknown ? Acute hypoxic respriatory failure due to COVID-19   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: AKI (acute kidney injury)  [N17.9] Supratherapeutic INR [R79.1] Hematoma of rectus sheath, initial encounter [S30.1XXA] COVID [U07.1] COVID-19 [U07.1] Respiratory arrest [R09.2]   HOSPITAL COURSE: Patient is a 69 y.o. male with a past medical history of metastatic prostate cancer, hypertension, hyperlipidemia, GERD, rheumatoid arthritis who presents today with symptoms of severe abdominal pain, cough and shortness of breath.  Patient states that he has been congested for approximately the last month with his significant other testing positive for COVID-19 1 week ago. He has continued coughing with sudden development of abdominal pain from coughing so much.   Upon arrival to facilitY, imaging was performed showing large right rectus sheath hematoma without evidence of active bleeding.  Patient does take Coumadin at home and was noted to be supratherapeutic on coagulation studies.  Patient was also found to be COVID-19 positive with no evidence of pneumonia on chest x-ray.  Patient did receive 1 dose of vitamin K in the emergency department for supratherapeutic INR of 8. Patient was initially admitted today oncology service for further treatment. While on the floor he had significant desaturation and ultimately a code blue is called. He receives one round of compressions and epinephrine and ROSC is achieved. He is intubated and requires multiple pressors for circulatory support.    Upon admission to the ICU the patient has a central and arterial line placed. He is found to have a 3g Hbg drop and has increasing pressor requirements. During his stay in the ICU he eventually required CRRT for worsening kidney function. He required 4 pressors and stress dose steroids with poor prognosis.  On 11/11/2022, resident team called significant other and 1st degree sister to discuss ongoing need for dialysis and raising pressor requirements despite adequate volume resuscitation.  Both of them agreed in his current state he would not want repeat resuscitation with chest compressions and code status was changed to do not resuscitate.  Around 8:00 p.m. on the same day, patient's pressor requirements increasing and lactate continues to up trend. Patient's significant other as well as only first degree sister were contacted regarding worsening clinical status. Both expressed that patient would have not wanted to pursue aggressive medical care in this clinical sitting as things don't seem to be improving. Goals of cares were discussed and both parties expressed their wishes totransition to comfort care.  At around 3:15 a.m., resident team called to bedside to pronounce patient death.  Patient was seen and examined, time of death was 3:25 a.m. on 11/12/2022.
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Haemoglobin, Haemoglobin decreased, Intensive care, Oxygen saturation, Oxygen saturation decreased
Clinical narrative: COVID+ 11/8/2022 - Vaccination status J&J x1 BRIEF OVERVIEW: Discharge Provider: DO Primary Care Physician at Discharge: DO   Admission Date: 11/8/2022   Active Hospital Problems   Diagnosis Date Noted POA ? COVID-19 11/09/2022 Unknown ? Acute hypoxic respriatory failure due to COVID-19   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: AKI (acute kidney injury)  [N17.9] Supratherapeutic INR [R79.1] Hematoma of rectus sheath, initial encounter [S30.1XXA] COVID [U07.1] COVID-19 [U07.1] Respiratory arrest [R09.2]   HOSPITAL COURSE: Patient is a 69 y.o. male with a past medical history of metastatic prostate cancer, hypertension, hyperlipidemia, GERD, rheumatoid arthritis who presents today with symptoms of severe abdominal pain, cough and shortness of breath.  Patient states that he has been congested for approximately the last month with his significant other testing positive for COVID-19 1 week ago. He has continued coughing with sudden development of abdominal pain from coughing so much.   Upon arrival to facilitY, imaging was performed showing large right rectus sheath hematoma without evidence of active bleeding.  Patient does take Coumadin at home and was noted to be supratherapeutic on coagulation studies.  Patient was also found to be COVID-19 positive with no evidence of pneumonia on chest x-ray.  Patient did receive 1 dose of vitamin K in the emergency department for supratherapeutic INR of 8. Patient was initially admitted today oncology service for further treatment. While on the floor he had significant desaturation and ultimately a code blue is called. He receives one round of compressions and epinephrine and ROSC is achieved. He is intubated and requires multiple pressors for circulatory support.    Upon admission to the ICU the patient has a central and arterial line placed. He is found to have a 3g Hbg drop and has increasing pressor requirements. During his stay in the ICU he eventually required CRRT for worsening kidney function. He required 4 pressors and stress dose steroids with poor prognosis.  On 11/11/2022, resident team called significant other and 1st degree sister to discuss ongoing need for dialysis and raising pressor requirements despite adequate volume resuscitation.  Both of them agreed in his current state he would not want repeat resuscitation with chest compressions and code status was changed to do not resuscitate.  Around 8:00 p.m. on the same day, patient's pressor requirements increasing and lactate continues to up trend. Patient's significant other as well as only first degree sister were contacted regarding worsening clinical status. Both expressed that patient would have not wanted to pursue aggressive medical care in this clinical sitting as things don't seem to be improving. Goals of cares were discussed and both parties expressed their wishes totransition to comfort care.  At around 3:15 a.m., resident team called to bedside to pronounce patient death.  Patient was seen and examined, time of death was 3:25 a.m. on 11/12/2022.
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Renal impairment, Respiratory arrest, Respiratory tract congestion, Resuscitation, SARS-CoV-2 test
Clinical narrative: COVID+ 11/8/2022 - Vaccination status J&J x1 BRIEF OVERVIEW: Discharge Provider: DO Primary Care Physician at Discharge: DO   Admission Date: 11/8/2022   Active Hospital Problems   Diagnosis Date Noted POA ? COVID-19 11/09/2022 Unknown ? Acute hypoxic respriatory failure due to COVID-19   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: AKI (acute kidney injury)  [N17.9] Supratherapeutic INR [R79.1] Hematoma of rectus sheath, initial encounter [S30.1XXA] COVID [U07.1] COVID-19 [U07.1] Respiratory arrest [R09.2]   HOSPITAL COURSE: Patient is a 69 y.o. male with a past medical history of metastatic prostate cancer, hypertension, hyperlipidemia, GERD, rheumatoid arthritis who presents today with symptoms of severe abdominal pain, cough and shortness of breath.  Patient states that he has been congested for approximately the last month with his significant other testing positive for COVID-19 1 week ago. He has continued coughing with sudden development of abdominal pain from coughing so much.   Upon arrival to facilitY, imaging was performed showing large right rectus sheath hematoma without evidence of active bleeding.  Patient does take Coumadin at home and was noted to be supratherapeutic on coagulation studies.  Patient was also found to be COVID-19 positive with no evidence of pneumonia on chest x-ray.  Patient did receive 1 dose of vitamin K in the emergency department for supratherapeutic INR of 8. Patient was initially admitted today oncology service for further treatment. While on the floor he had significant desaturation and ultimately a code blue is called. He receives one round of compressions and epinephrine and ROSC is achieved. He is intubated and requires multiple pressors for circulatory support.    Upon admission to the ICU the patient has a central and arterial line placed. He is found to have a 3g Hbg drop and has increasing pressor requirements. During his stay in the ICU he eventually required CRRT for worsening kidney function. He required 4 pressors and stress dose steroids with poor prognosis.  On 11/11/2022, resident team called significant other and 1st degree sister to discuss ongoing need for dialysis and raising pressor requirements despite adequate volume resuscitation.  Both of them agreed in his current state he would not want repeat resuscitation with chest compressions and code status was changed to do not resuscitate.  Around 8:00 p.m. on the same day, patient's pressor requirements increasing and lactate continues to up trend. Patient's significant other as well as only first degree sister were contacted regarding worsening clinical status. Both expressed that patient would have not wanted to pursue aggressive medical care in this clinical sitting as things don't seem to be improving. Goals of cares were discussed and both parties expressed their wishes totransition to comfort care.  At around 3:15 a.m., resident team called to bedside to pronounce patient death.  Patient was seen and examined, time of death was 3:25 a.m. on 11/12/2022.
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: COVID+ 11/8/2022 - Vaccination status J&J x1 BRIEF OVERVIEW: Discharge Provider: DO Primary Care Physician at Discharge: DO   Admission Date: 11/8/2022   Active Hospital Problems   Diagnosis Date Noted POA ? COVID-19 11/09/2022 Unknown ? Acute hypoxic respriatory failure due to COVID-19   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: AKI (acute kidney injury)  [N17.9] Supratherapeutic INR [R79.1] Hematoma of rectus sheath, initial encounter [S30.1XXA] COVID [U07.1] COVID-19 [U07.1] Respiratory arrest [R09.2]   HOSPITAL COURSE: Patient is a 69 y.o. male with a past medical history of metastatic prostate cancer, hypertension, hyperlipidemia, GERD, rheumatoid arthritis who presents today with symptoms of severe abdominal pain, cough and shortness of breath.  Patient states that he has been congested for approximately the last month with his significant other testing positive for COVID-19 1 week ago. He has continued coughing with sudden development of abdominal pain from coughing so much.   Upon arrival to facilitY, imaging was performed showing large right rectus sheath hematoma without evidence of active bleeding.  Patient does take Coumadin at home and was noted to be supratherapeutic on coagulation studies.  Patient was also found to be COVID-19 positive with no evidence of pneumonia on chest x-ray.  Patient did receive 1 dose of vitamin K in the emergency department for supratherapeutic INR of 8. Patient was initially admitted today oncology service for further treatment. While on the floor he had significant desaturation and ultimately a code blue is called. He receives one round of compressions and epinephrine and ROSC is achieved. He is intubated and requires multiple pressors for circulatory support.    Upon admission to the ICU the patient has a central and arterial line placed. He is found to have a 3g Hbg drop and has increasing pressor requirements. During his stay in the ICU he eventually required CRRT for worsening kidney function. He required 4 pressors and stress dose steroids with poor prognosis.  On 11/11/2022, resident team called significant other and 1st degree sister to discuss ongoing need for dialysis and raising pressor requirements despite adequate volume resuscitation.  Both of them agreed in his current state he would not want repeat resuscitation with chest compressions and code status was changed to do not resuscitate.  Around 8:00 p.m. on the same day, patient's pressor requirements increasing and lactate continues to up trend. Patient's significant other as well as only first degree sister were contacted regarding worsening clinical status. Both expressed that patient would have not wanted to pursue aggressive medical care in this clinical sitting as things don't seem to be improving. Goals of cares were discussed and both parties expressed their wishes totransition to comfort care.  At around 3:15 a.m., resident team called to bedside to pronounce patient death.  Patient was seen and examined, time of death was 3:25 a.m. on 11/12/2022.
Age: 7.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: The booster dose was monovalent, not bivalent
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Fatigue, Nasal congestion, Oropharyngeal pain, SARS-CoV-2 test positive
Clinical narrative: 11/6/22 That morning I had a stuffy nose and sore throat. My husband had tested positive, and I tested negative. I tested with a home test and was positive. Drank a lot of water, was seen by an APN and started Paxlovid that evening. I did not feel any worse for a few days, just tired.  By the sixth or seventh day, I felt completely normal. I tested again on 11/10/22 and was negative.  I feel fine, back to normal.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Discomfort, Ear pain, Endoscopy, Oropharyngeal pain
Clinical narrative: 4 months after the vaccine I started getting earache and sore throat. The doctor used a scope to take a look down my throat and did not find anything. The doctor asked me to monitor it. My symptoms have improved but I still have slight discomfort. I was not prescribed any medicine to treat the symptoms.
Age: 9.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: The booster dose was monovalent, not bivalent
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Autopsy, Eosinophilic myocarditis, Histology
Clinical narrative: Post-mortem examination of cardiac tissue revealed eosinophilic myocarditis.
Age: 41.0
Sex: F
Vaccine: COVID19-2
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth, Lymph node pain, Lymphadenopathy
Clinical narrative: Pain and swelling in lymph nodes under right arm were the issue of concern. Patient did also run a fever (100-102) for 3+ days after receiving injection. Note that injection site swelled, turned red, and radiated heat in about a 5-8" circle around the injection. Patient called primary care doctor due to concern when lymph nodes' swelling and pain did not improve 36 hours after onset. PCP advised ibuprofen, application of heat (patient was already doing this), and to visit the ER if symptoms did not improve within 2 more days.   After 30 more hours (from talking to PCP), swelling and tenderness lessened (though still present). This was approx. 90 hours after injection. Patient agreed to report adverse reaction and follow-up with PCP if needed.
Age: 41.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pyrexia, Tenderness
Clinical narrative: Pain and swelling in lymph nodes under right arm were the issue of concern. Patient did also run a fever (100-102) for 3+ days after receiving injection. Note that injection site swelled, turned red, and radiated heat in about a 5-8" circle around the injection. Patient called primary care doctor due to concern when lymph nodes' swelling and pain did not improve 36 hours after onset. PCP advised ibuprofen, application of heat (patient was already doing this), and to visit the ER if symptoms did not improve within 2 more days.   After 30 more hours (from talking to PCP), swelling and tenderness lessened (though still present). This was approx. 90 hours after injection. Patient agreed to report adverse reaction and follow-up with PCP if needed.
Age: 50.0
Sex: F
Vaccine: COVID19-2
Symptoms: Blood test normal, Ear discomfort, Head discomfort, Headache, Magnetic resonance imaging head normal
Clinical narrative: I have had an almost constant headache for the past several months. I cannot be absolutely certain when the headache started, but I know it was near the end of September. It IS possible that the headache started before my last COVID shot. I am not generally a headache person and I am in otherwise good health.  My doctor says that my symptoms sound like a tension headache.  I feel stress, yes, but no more than I have had over the last few years. I feel an almost constant pressure in my head. Sometimes, upon a change in position, the pressure builds up momentarily to the point where I need to pause and close my eyes. My ears also have pressure in them. My doctor has checked for a sinus infection and prescribed antibiotics just in case, and I have had an MRI which no brain abnormalities and indicated that my sinuses are clear.  Medication like ibuprofen *sometimes* provides temporary relief, but the pressure always returns.  It's not debilitating, but it is frustrating.  I just recently started taking loratadine to see if that helps -- maybe the headache is due to seasonal allergies -- but it seems like a long time for that to be the case. So far, the loratadine has not helped.
Age: 50.0
Sex: F
Vaccine: COVID19-2
Symptoms: Stress, Tension headache
Clinical narrative: I have had an almost constant headache for the past several months. I cannot be absolutely certain when the headache started, but I know it was near the end of September. It IS possible that the headache started before my last COVID shot. I am not generally a headache person and I am in otherwise good health.  My doctor says that my symptoms sound like a tension headache.  I feel stress, yes, but no more than I have had over the last few years. I feel an almost constant pressure in my head. Sometimes, upon a change in position, the pressure builds up momentarily to the point where I need to pause and close my eyes. My ears also have pressure in them. My doctor has checked for a sinus infection and prescribed antibiotics just in case, and I have had an MRI which no brain abnormalities and indicated that my sinuses are clear.  Medication like ibuprofen *sometimes* provides temporary relief, but the pressure always returns.  It's not debilitating, but it is frustrating.  I just recently started taking loratadine to see if that helps -- maybe the headache is due to seasonal allergies -- but it seems like a long time for that to be the case. So far, the loratadine has not helped.
Age: 37.0
Sex: F
Vaccine: COVID19-2
Symptoms: Chills, Headache, Night sweats, Pain, Pyrexia
Clinical narrative: Slight fever, chills, excessive night sweats, headache, achy all over body
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pruritus, Pyrexia, Rash
Clinical narrative: received the Moderna booster on 1/19. He had a fever the day following the vaccine and felt fatigued. He developed pruritis and rash this past Saturday (1/29). He has taken benadryl for the itching. Reports some relief after soaking in a hot bath with epsom salt. He denies fever, sob, chest tightness.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Autoimmune hypothyroidism, Autoimmune thyroiditis, Blood pressure abnormal, Chest pain, Dizziness
Clinical narrative: Diagnosed with autoimmune hypothyroidism-Hashimotos on Jan 6, 2022.-Related to immune system Diagnosed with squamous cell skin cancer August 2022-Related to immune system. Diagnosed with shingles Nov 4, 2022 even though I've had 2 shingles vaccines-Related to immune system Cardiac symptoms-SOB, Chest Pain, erratic heart rate and BP, lightheadedness, facial numbness began in Spring of 2022 and intensified in June-September,  Diagnosed with SVT but all symptoms not explained.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Heart rate abnormal, Herpes zoster, Hypoaesthesia, Laboratory test
Clinical narrative: Diagnosed with autoimmune hypothyroidism-Hashimotos on Jan 6, 2022.-Related to immune system Diagnosed with squamous cell skin cancer August 2022-Related to immune system. Diagnosed with shingles Nov 4, 2022 even though I've had 2 shingles vaccines-Related to immune system Cardiac symptoms-SOB, Chest Pain, erratic heart rate and BP, lightheadedness, facial numbness began in Spring of 2022 and intensified in June-September,  Diagnosed with SVT but all symptoms not explained.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Squamous cell carcinoma of skin, Supraventricular tachycardia
Clinical narrative: Diagnosed with autoimmune hypothyroidism-Hashimotos on Jan 6, 2022.-Related to immune system Diagnosed with squamous cell skin cancer August 2022-Related to immune system. Diagnosed with shingles Nov 4, 2022 even though I've had 2 shingles vaccines-Related to immune system Cardiac symptoms-SOB, Chest Pain, erratic heart rate and BP, lightheadedness, facial numbness began in Spring of 2022 and intensified in June-September,  Diagnosed with SVT but all symptoms not explained.
Age: 11.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: The booster dose was monovalent, not bivalent
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: A Movovalent Covid-19 vaccine was given instead of a Bivalent dose to patient. Both vials have gray top's and the employee pulled the wrong gray top vaccine.  Notification: Via phone on 11/14/22
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: The booster dose was monovalent, not bivalent
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Nerve injury
Clinical narrative: patient says she has had nerve damage and has seen a therapist since
Age: 65.0
Sex: F
Vaccine: PNC20, VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site urticaria
Clinical narrative: Left arm  2" diameter sized reddish spot at injection site, noticed early next morning, slight soreness, no itch That evening there was a large pink area (hives) between inj. site and elbow  4"diameter,  no pain, no itch   Over next couple of days area didn't increase in size, but started itching slightly By Nov15, redness disappeared.  Slight itching occasionally yet.
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: The booster dose was monovalent, not bivalent
Age: 75.0
Sex: F
Vaccine: COVID19-2
Symptoms: Ageusia, Anosmia, Bronchitis, COVID-19, Chiropractic
Clinical narrative: On 10/02/2022, I felt like spikes being hammered on the left side of my head, and they would come and go. It continued for several days. I went to my chiropractor on 10/04/2022. They did an adjustment and they attributed to a side effect of the booster. On the 10/11/2022 I went to my doctor and the doctor agreed it was probably a side effect of the booster and told me to take Tylenol to help with the pain. On 10/14/2022, I was exposed to COVID-19 and on 10/18/2022 I tested positive for COVID-19. I was starting to feel achy and very tired and had a headache, and just slept. The next day I contacted my doctor through telehealth. My head was fuzzy. The doctor prescribed Malnupiravir because she thought it would have less side effects than the Paxlovid. I never quite recovered. I started to feel a little better that I went to my dentist on 10/31/2022. I had laser surgery on 11/1/2022. The next day, I got RSV and I was kind of down again. I had never fully recovered from COVID and then on top of this, RSV. Then I developed bronchitis on 11/6/2022. I never felt like I completely got. I tested positive for influenza A on 11/8/2022. At that point the doctor prescribed Doxycycline for the bronchitis. Currently I still have a lot of fatigue and a cough. My smell and taste has come back a little, but not completely at all. I have about 4 more days of the Doxycycline. I have had this brain fog, fuzzy, dizzy, I have had a difficulty with memory and concentration.
Age: 75.0
Sex: F
Vaccine: COVID19-2
Symptoms: Cough, Disturbance in attention, Dizziness, Exposure to SARS-CoV-2, Fatigue
Clinical narrative: On 10/02/2022, I felt like spikes being hammered on the left side of my head, and they would come and go. It continued for several days. I went to my chiropractor on 10/04/2022. They did an adjustment and they attributed to a side effect of the booster. On the 10/11/2022 I went to my doctor and the doctor agreed it was probably a side effect of the booster and told me to take Tylenol to help with the pain. On 10/14/2022, I was exposed to COVID-19 and on 10/18/2022 I tested positive for COVID-19. I was starting to feel achy and very tired and had a headache, and just slept. The next day I contacted my doctor through telehealth. My head was fuzzy. The doctor prescribed Malnupiravir because she thought it would have less side effects than the Paxlovid. I never quite recovered. I started to feel a little better that I went to my dentist on 10/31/2022. I had laser surgery on 11/1/2022. The next day, I got RSV and I was kind of down again. I had never fully recovered from COVID and then on top of this, RSV. Then I developed bronchitis on 11/6/2022. I never felt like I completely got. I tested positive for influenza A on 11/8/2022. At that point the doctor prescribed Doxycycline for the bronchitis. Currently I still have a lot of fatigue and a cough. My smell and taste has come back a little, but not completely at all. I have about 4 more days of the Doxycycline. I have had this brain fog, fuzzy, dizzy, I have had a difficulty with memory and concentration.
Age: 75.0
Sex: F
Vaccine: COVID19-2
Symptoms: Feeling abnormal, Head discomfort, Headache, Immunisation reaction, Influenza A virus test positive
Clinical narrative: On 10/02/2022, I felt like spikes being hammered on the left side of my head, and they would come and go. It continued for several days. I went to my chiropractor on 10/04/2022. They did an adjustment and they attributed to a side effect of the booster. On the 10/11/2022 I went to my doctor and the doctor agreed it was probably a side effect of the booster and told me to take Tylenol to help with the pain. On 10/14/2022, I was exposed to COVID-19 and on 10/18/2022 I tested positive for COVID-19. I was starting to feel achy and very tired and had a headache, and just slept. The next day I contacted my doctor through telehealth. My head was fuzzy. The doctor prescribed Malnupiravir because she thought it would have less side effects than the Paxlovid. I never quite recovered. I started to feel a little better that I went to my dentist on 10/31/2022. I had laser surgery on 11/1/2022. The next day, I got RSV and I was kind of down again. I had never fully recovered from COVID and then on top of this, RSV. Then I developed bronchitis on 11/6/2022. I never felt like I completely got. I tested positive for influenza A on 11/8/2022. At that point the doctor prescribed Doxycycline for the bronchitis. Currently I still have a lot of fatigue and a cough. My smell and taste has come back a little, but not completely at all. I have about 4 more days of the Doxycycline. I have had this brain fog, fuzzy, dizzy, I have had a difficulty with memory and concentration.
Age: 75.0
Sex: F
Vaccine: COVID19-2
Symptoms: Memory impairment, Pain, Respiratory syncytial virus infection, SARS-CoV-2 test positive, Surgery
Clinical narrative: On 10/02/2022, I felt like spikes being hammered on the left side of my head, and they would come and go. It continued for several days. I went to my chiropractor on 10/04/2022. They did an adjustment and they attributed to a side effect of the booster. On the 10/11/2022 I went to my doctor and the doctor agreed it was probably a side effect of the booster and told me to take Tylenol to help with the pain. On 10/14/2022, I was exposed to COVID-19 and on 10/18/2022 I tested positive for COVID-19. I was starting to feel achy and very tired and had a headache, and just slept. The next day I contacted my doctor through telehealth. My head was fuzzy. The doctor prescribed Malnupiravir because she thought it would have less side effects than the Paxlovid. I never quite recovered. I started to feel a little better that I went to my dentist on 10/31/2022. I had laser surgery on 11/1/2022. The next day, I got RSV and I was kind of down again. I had never fully recovered from COVID and then on top of this, RSV. Then I developed bronchitis on 11/6/2022. I never felt like I completely got. I tested positive for influenza A on 11/8/2022. At that point the doctor prescribed Doxycycline for the bronchitis. Currently I still have a lot of fatigue and a cough. My smell and taste has come back a little, but not completely at all. I have about 4 more days of the Doxycycline. I have had this brain fog, fuzzy, dizzy, I have had a difficulty with memory and concentration.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Who: Patient What: A Movovalent Covid-19 vaccine was given instead of a Bivalent dose to patient. Both vials have gray top's and the PHN pulled the wrong gray top vaccine. Where: location Notification: Via phone on 11/14/22
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Angiogram pulmonary abnormal, Body temperature increased, Bronchial wall thickening, COVID-19, Cardiomegaly
Clinical narrative: COVID+ 11/11/22 - Vaccination status - moderna x3   BRIEF OVERVIEW: Discharge Provider: DO Primary Care Provider at Discharge: MD Admission Date: 11/11/2022 Discharge Date: 11/13/2022    Active Hospital Problems   Diagnosis Date Noted POA ? COVID 11/11/2022 Yes ? Chronic systolic heart failure (HCC) 11/11/2022 Yes ? History of atrial fibrillation 05/04/2020 Yes ? Anxiety and depression 12/03/2019 Yes ? Hyperlipidemia 10/02/2019 Yes ? BPH (benign prostatic hyperplasia) 10/02/2019 Yes ? Morbid obesity (HCC) 03/28/2018 Yes ? Type 2 diabetes mellitus with complication, without long-term current use of insulin (HCC) 03/28/2018 Yes   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hypoxia  Sepsis, due to unspecified organism, unspecified whether acute organ dysfunction present (HCC) COVID-19   HOSPITAL COURSE: 73-year-old gentleman with known history of diabetes atrial fibrillation presents to the emergency department with worsening shortness of breath.  Patient also with increased cough.  Patient diagnosed with COVID-19 in the emergency department.  Patient had received his vaccinations up to the 1st booster.  Patient had a low-grade temperature tachycardic increased respiratory rate on presentation.  Oxygen saturations were 78% on room air.  Patient was placed on 3 L per nasal cannula admitted to the hospital.  He was given Decadron.  There was also some concerns about possible mild pulmonary edema on presentation.  CT angiogram was done coming in which did show bronchial wall thickening but no evidence of PE.     Over the next 2 days patient's respiratory status improved significantly.  He was able to be weaned from room air.  Patient was anxious for discharge to home.  Since his clinical conditions has stabilized going to be discharged home.   Of note patient had elevated blood sugars are hospitalization most likely 2nd to steroids.  His hemoglobin A1 c has increased to 11.2 from 9.8 prior.  Patient does admit to drinking regular soda pop frequently at home.  He also does not check his blood sugars.  Patient was previously on metformin but was unable to tolerate.  He states a caused him diarrhea.  He currently is on Actos.  We discussed that is Actos may be contributing to his lower extremity edema.  We also discussed that he should  follow-up with his primary care physician to discuss appropriate medications to start on as an outpatient.  Patient is hesitant to want to be taking insulin.   Patient also had cardiomegaly on CT scan.  Wife asked about a. Patient did have an echocardiogram ordered in August.  Both him and his wife for unaware that this was ordered.  They been encouraged to follow-up with primary care back to get a repeat echo done.   At the time of discharge all questions have been answered.  Of course of patient's worsening shortness of breath develops high fevers chills or feels his clinical condition is deteriorating anyway he should call his primary care physician or return to the emergency department immediately for further evaluation.